{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:48:57Z","timestamp":1791823737371,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan Science and Technology Department youth Foundation project","award":["2023NSFSC1882"],"award-info":[{"award-number":["2023NSFSC1882"]}]},{"name":"Sichuan Science and Technology Department youth Foundation project","award":["2023NSFSC1882"],"award-info":[{"award-number":["2023NSFSC1882"]}]},{"name":"Sichuan Science and Technology Department youth Foundation project","award":["2023NSFSC1882"],"award-info":[{"award-number":["2023NSFSC1882"]}]},{"name":"Sichuan Science and Technology Department youth Foundation project","award":["2023NSFSC1882"],"award-info":[{"award-number":["2023NSFSC1882"]}]},{"name":"Sichuan Science and Technology Department youth Foundation project","award":["2023NSFSC1882"],"award-info":[{"award-number":["2023NSFSC1882"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03681-8","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:56:32Z","timestamp":1784199392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PPP2R2C promotes aerobic glycolysis and mediates pemetrexed resistance in lung adenocarcinomas by upregulating TCP1-dependent protein folding of glycolytic enzymes"],"prefix":"10.1186","volume":"27","author":[{"given":"Jia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"3681_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3681_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-021-00824-9","volume":"7","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang Y, Wang C, Yang Y, Ni Y, Wang Z, Song T, Yao M, Liu Z, Chao N, et al. Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer. Signal Transduct Target Ther. 2022;7:9.","journal-title":"Signal Transduct Target Ther"},{"key":"3681_CR3","first-page":"167","volume":"27","author":"S Jonna","year":"2019","unstructured":"Jonna S, Subramaniam DS. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med. 2019;27:167\u201370.","journal-title":"Discov Med"},{"key":"3681_CR4","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.jtho.2019.06.011","volume":"14","author":"H Balata","year":"2019","unstructured":"Balata H, Fong KM, Hendriks LE, Lam S, Ostroff JS, Peled N, Wu N, Aggarwal C. Prevention and Early Detection for NSCLC: Advances in Thoracic Oncology 2018. J Thorac Oncol. 2019;14:1513\u201327.","journal-title":"J Thorac Oncol"},{"key":"3681_CR5","doi-asserted-by":"publisher","first-page":"1016217","DOI":"10.3389\/fonc.2022.1016217","volume":"12","author":"A Dhawan","year":"2022","unstructured":"Dhawan A, Pifer PM, Sandulache VC, Skinner HD. Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here? Front Oncol. 2022;12:1016217.","journal-title":"Front Oncol"},{"key":"3681_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2007.06.034","volume":"130","author":"M Mumby","year":"2007","unstructured":"Mumby M. PP2A: unveiling a reluctant tumor suppressor. Cell. 2007;130:21\u20134.","journal-title":"Cell"},{"key":"3681_CR7","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1016\/S1470-2045(12)70558-2","volume":"14","author":"D Perrotti","year":"2013","unstructured":"Perrotti D, Neviani P. Protein phosphatase 2A: a target for anticancer therapy. Lancet Oncol. 2013;14:e229\u2013238.","journal-title":"Lancet Oncol"},{"key":"3681_CR8","doi-asserted-by":"publisher","first-page":"188578","DOI":"10.1016\/j.bbcan.2021.188578","volume":"1876","author":"EC Dacol","year":"2021","unstructured":"Dacol EC, Wang S, Chen Y, Lepique AP. The interaction of SET and protein phosphatase 2A as target for cancer therapy. Biochim Biophys Acta Rev Cancer. 2021;1876:188578.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3681_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/1873-3468.12907","volume":"592","author":"G Taleski","year":"2018","unstructured":"Taleski G, Sontag E. Protein phosphatase 2A and tau: an orchestrated \u2018Pas de Deux\u2019. FEBS Lett. 2018;592:1079\u201395.","journal-title":"FEBS Lett"},{"key":"3681_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ejmg.2010.06.006","volume":"53","author":"L Backx","year":"2010","unstructured":"Backx L, Vermeesch J, Pijkels E, de Ravel T, Seuntjens E, Van Esch H. PPP2R2C, a gene disrupted in autosomal dominant intellectual disability. Eur J Med Genet. 2010;53:239\u201343.","journal-title":"Eur J Med Genet"},{"key":"3681_CR11","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.18632\/aging.103048","volume":"12","author":"W Leong","year":"2020","unstructured":"Leong W, Xu W, Wang B, Gao S, Zhai X, Wang C, Gilson E, Ye J, Lu Y. PP2A subunit PPP2R2C is downregulated in the brains of Alzheimer\u2019s transgenic mice. Aging. 2020;12:6880\u201390.","journal-title":"Aging"},{"key":"3681_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1158\/1541-7786.MCR-12-0710","volume":"11","author":"EG Bluemn","year":"2013","unstructured":"Bluemn EG, Spencer ES, Mecham B, Gordon RR, Coleman I, Lewinshtein D, Mostaghel E, Zhang X, Annis J, Grandori C, et al. PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality. Mol Cancer Res. 2013;11:568\u201378.","journal-title":"Mol Cancer Res"},{"key":"3681_CR13","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1016\/j.febslet.2013.09.029","volume":"587","author":"YL Fan","year":"2013","unstructured":"Fan YL, Chen L, Wang J, Yao Q, Wan JQ. Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway. FEBS Lett. 2013;587:3892\u20137.","journal-title":"FEBS Lett"},{"key":"3681_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biopha.2016.03.043","volume":"81","author":"D Bi","year":"2016","unstructured":"Bi D, Ning H, Liu S, Que X, Ding K. miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C. Biomed Pharmacother. 2016;81:25\u201330.","journal-title":"Biomed Pharmacother"},{"key":"3681_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biopha.2015.12.005","volume":"77","author":"AH Wu","year":"2016","unstructured":"Wu AH, Huang YL, Zhang LZ, Tian G, Liao QZ, Chen SL. MiR-572 prompted cell proliferation of human ovarian cancer cells by suppressing PPP2R2C expression. Biomed Pharmacother. 2016;77:92\u20137.","journal-title":"Biomed Pharmacother"},{"key":"3681_CR16","doi-asserted-by":"publisher","first-page":"300060520950912","DOI":"10.1177\/0300060520950912","volume":"48","author":"X Peng","year":"2020","unstructured":"Peng X, Yu M, Chen J. Transcriptome sequencing identifies genes associated with invasion of ovarian cancer. J Int Med Res. 2020;48:300060520950912.","journal-title":"J Int Med Res"},{"key":"3681_CR17","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.7717\/peerj.49","volume":"1","author":"W Liu","year":"2013","unstructured":"Liu W, Peng Y, Tobin DJ. A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis. PeerJ. 2013;1:e49.","journal-title":"PeerJ"},{"key":"3681_CR18","doi-asserted-by":"publisher","first-page":"e11069","DOI":"10.1590\/1414-431x2020e11069","volume":"54","author":"W Ma","year":"2021","unstructured":"Ma W, Cao Q, She W. Identification and clinical validation of gene signatures with grade and survival in head and neck carcinomas. Braz J Med Biol Res. 2021;54:e11069.","journal-title":"Braz J Med Biol Res"},{"key":"3681_CR19","doi-asserted-by":"publisher","first-page":"e9086","DOI":"10.7717\/peerj.9086","volume":"8","author":"X Ma","year":"2020","unstructured":"Ma X, Ren H, Peng R, Li Y, Ming L. Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma. PeerJ. 2020;8:e9086.","journal-title":"PeerJ"},{"key":"3681_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-biochem-060208-092442","volume":"82","author":"YE Kim","year":"2013","unstructured":"Kim YE, Hipp MS, Bracher A, Hayer-Hartl M, Hartl FU. Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem. 2013;82:323\u201355.","journal-title":"Annu Rev Biochem"},{"key":"3681_CR21","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.drup.2019.100663","volume":"48","author":"S Narayanan","year":"2020","unstructured":"Narayanan S, Cai CY, Assaraf YG, Guo HQ, Cui Q, Wei L, Huang JJ, Ashby CR Jr., Chen ZS. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance. Drug Resist Updat. 2020;48:100663.","journal-title":"Drug Resist Updat"},{"key":"3681_CR22","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","volume":"187","author":"SM Fendt","year":"2024","unstructured":"Fendt SM. 100 years of the Warburg effect: A cancer metabolism endeavor. Cell. 2024;187:3824\u20138.","journal-title":"Cell"},{"key":"3681_CR23","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.yexcr.2006.03.028","volume":"312","author":"J Grantham","year":"2006","unstructured":"Grantham J, Brackley KI, Willison KR. Substantial CCT activity is required for cell cycle progression and cytoskeletal organization in mammalian cells. Exp Cell Res. 2006;312:2309\u201324.","journal-title":"Exp Cell Res"},{"key":"3681_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12967-024-05284-7","volume":"22","author":"SK Yu","year":"2024","unstructured":"Yu SK, Yu T, Wang YM, Sun A, Liu J, Lu KH. CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1\/HK2 axis. J Transl Med. 2024;22:460.","journal-title":"J Transl Med"},{"key":"3681_CR25","doi-asserted-by":"publisher","first-page":"e38387","DOI":"10.1097\/MD.0000000000038387","volume":"103","author":"R Du","year":"2024","unstructured":"Du R, Zhou Z, Huang Y, Li K, Guo K, Han L, Bian H. Chaperonin-containing TCP-1 subunit genes are potential prognostic biomarkers and are correlated with Th2 cell infiltration in lung adenocarcinoma: An observational study. Med (Baltim). 2024;103:e38387.","journal-title":"Med (Baltim)"},{"key":"3681_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11:39\u201351.","journal-title":"J Thorac Oncol"},{"key":"3681_CR27","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1111\/j.1742-4658.2006.05520.x","volume":"273","author":"RA Gomes","year":"2006","unstructured":"Gomes RA, Vicente Miranda H, Silva MS, Gra\u00e7a G, Coelho AV, Ferreira AE, Cordeiro C, Freire AP. Yeast protein glycation in vivo by methylglyoxal. Molecular modification of glycolytic enzymes and heat shock proteins. Febs j. 2006;273:5273\u201387.","journal-title":"Febs j"},{"key":"3681_CR28","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/pro.3880","volume":"29","author":"C Chen","year":"2020","unstructured":"Chen C, Park C. Chaperone action of a cofactor in protein folding. Protein Sci. 2020;29:1667\u201378.","journal-title":"Protein Sci"},{"key":"3681_CR29","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.molcel.2023.02.009","volume":"83","author":"M Carraro","year":"2023","unstructured":"Carraro M, Hendriks IA, Hammond CM, Solis-Mezarino V, V\u00f6lker-Albert M, Elsborg JD, Weisser MB, Spanos C, Montoya G, Rappsilber J, et al. DAXX adds a de novo H3.3K9me3 deposition pathway to the histone chaperone network. Mol Cell. 2023;83:1075\u2013e10921079.","journal-title":"Mol Cell"},{"key":"3681_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12935-015-0164-6","volume":"15","author":"YN Li","year":"2015","unstructured":"Li YN, Cao YQ, Wu X, Han GS, Wang LX, Zhang YH, Chen X, Hao B, Yue ZJ, Liu JM. The association between Salt-inducible kinase 2 (SIK2) and gamma isoform of the regulatory subunit B55 of PP2A (B55gamma) contributes to the survival of glioma cells under glucose depletion through inhibiting the phosphorylation of S6K. Cancer Cell Int. 2015;15:21.","journal-title":"Cancer Cell Int"},{"key":"3681_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41568-021-00423-4","volume":"22","author":"SS Hecht","year":"2022","unstructured":"Hecht SS, Hatsukami DK. Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention. Nat Rev Cancer. 2022;22:143\u201355.","journal-title":"Nat Rev Cancer"},{"key":"3681_CR32","doi-asserted-by":"crossref","unstructured":"Zhong W, Cui L, Goh BC, Cai Q, Ho P, Chionh YH, Yuan M, Sahili AE, Fothergill-Gilmore LA, Walkinshaw MD et al. Allosteric pyruvate kinase-based logic gate synergistically senses energy and sugar levels in Mycobacterium tuberculosis. Nat Commun 2017; 8:1986.","DOI":"10.1038\/s41467-017-02086-y"},{"key":"3681_CR33","doi-asserted-by":"publisher","first-page":"101846","DOI":"10.1016\/j.tranon.2023.101846","volume":"40","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Esbati N, Rashidi M, Gholami S, Raesi R, Bidoki SS, Goharrizi MASB, Motlagh YSM, Khorrami R, Tavakolpournegari A, et al. Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. Translational Oncol. 2023;40:101846.","journal-title":"Translational Oncol"},{"key":"3681_CR34","doi-asserted-by":"publisher","first-page":"153303382312120","DOI":"10.1177\/15330338231212071","volume":"22","author":"Y Ruochen","year":"2023","unstructured":"Ruochen Y, Wenbin J, Chao G, Yuhua Y, Feng Q. SGMS1-AS1\/MicroRNA-106a-5p\/CPT2 Axis as a Novel Target for Regulating Lactate Metabolism in Colon Cancer. Technol Cancer Res Treat. 2023;22:15330338231212071.","journal-title":"Technol Cancer Res Treat"},{"key":"3681_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s12967-023-04403-0","volume":"21","author":"W Duan","year":"2023","unstructured":"Duan W, Liu W, Xia S, Zhou Y, Tang M, Xu M, Lin M, Li X, Wang Q. Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis. J Transl Med. 2023;21:547.","journal-title":"J Transl Med"},{"key":"3681_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13048-021-00832-x","volume":"14","author":"H Weng","year":"2021","unstructured":"Weng H, Feng X, Lan Y, Zheng Z. TCP1 regulates PI3K\/AKT\/mTOR signaling pathway to promote proliferation of ovarian cancer cells. J Ovarian Res. 2021;14:82.","journal-title":"J Ovarian Res"},{"key":"3681_CR37","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41419-021-04336-w","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, Chen X, Huang Y, Lin J, Wu Y, Chen Y. TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT\/mTOR signaling. Cell Death Dis. 2021;12:1058.","journal-title":"Cell Death Dis"},{"key":"3681_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s42003-025-07867-6","volume":"8","author":"H Liu","year":"2025","unstructured":"Liu H, Chen L, Chen Y, Jin Y, Chen X, Ma N, Yang F, Bi H, Wen X, Xu S, et al. TCP1 promotes the progression of malignant tumours by stabilizing c-Myc through the AKT\/GSK-3\u03b2 and ERK signalling pathways. Commun Biol. 2025;8:563.","journal-title":"Commun Biol"},{"key":"3681_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12885-023-10677-w","volume":"23","author":"J Huang","year":"2023","unstructured":"Huang J, Hu B, Yang Y, Liu H, Fan X, Zhou J, Chen L. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma. BMC Cancer. 2023;23:241.","journal-title":"BMC Cancer"},{"key":"3681_CR40","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21147\/j.issn.1000-9604.2025.06.11","volume":"37","author":"P Zhang","year":"2025","unstructured":"Zhang P, Liang X, Ye B, Wang X, Wang Y, Gong Z, Huang Y, Liu J, Huang C, Luo P. Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: Targeting SLC25A1 to overcome immune resistance. Chin J Cancer Res. 2025;37:1000\u201319.","journal-title":"Chin J Cancer Res"},{"key":"3681_CR41","doi-asserted-by":"publisher","first-page":"796","DOI":"10.21147\/j.issn.1000-9604.2025.05.11","volume":"37","author":"W Xia","year":"2025","unstructured":"Xia W, Liu J, Chen R, Feng J, Wu L, Wang Y, Wang X, Song C, Mao W. Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma. Chin J Cancer Res. 2025;37:796\u2013820.","journal-title":"Chin J Cancer Res"},{"key":"3681_CR42","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong Z, Du M, Li Y, Ye B, Huang Y, Gong H, Wang W, Chen L, Ding Z, Zhang P. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit Med. 2025;8:796.","journal-title":"NPJ Digit Med"},{"key":"3681_CR43","doi-asserted-by":"publisher","first-page":"55613","DOI":"10.18632\/oncotarget.14732","volume":"8","author":"L Jiang","year":"2017","unstructured":"Jiang L, Yuan GL, Liang QL, Zhang HJ, Huang J, Cheng SA, Peng XX. Positive expression of Y-box binding protein 1 and prognosis in non-small cell lung cancer: a meta-analysis. Oncotarget. 2017;8:55613\u201321.","journal-title":"Oncotarget"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03681-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:05:09Z","timestamp":1791821109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03681-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3681"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03681-8","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were conducted in strict accordance with the ARRIVE guidelines 2.0 and approved by the Ethics Committee of Sichuan Provincial People\u2019s Hospital (No. 2023\u2009\u2212\u2009226). Tumor burden was strictly monitored and did not exceed the maximum permitted size (2.0\u00a0cm in diameter or 2000\u00a0mm\u00b3 in volume for mice) as per institutional guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"391"}}